Cognitive Therapy for Suicide Prevention in Homeless Youth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial seeks an effective therapy to assist homeless youth dealing with suicidal thoughts, substance use, and depression. It compares a combination of Cognitive Therapy for Suicide Prevention (a type of talk therapy) with regular community services against community services alone. The goal is to determine if adding this therapy more effectively reduces suicidal thoughts. Youth who are homeless, have recently used alcohol or drugs, and have attempted suicide in the past year might be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity for participants to contribute to groundbreaking research that could enhance support for vulnerable youth.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that Cognitive Therapy for Suicide Prevention is safe for homeless youth?
Research has shown that Cognitive Therapy for Suicide Prevention (CTSP) is generally manageable for participants. In studies with homeless youth, CTSP greatly reduced suicidal thoughts and feelings of hopelessness. These studies did not report any serious negative effects from the therapy.
CTSP involves talk therapy sessions, which are safe as they do not involve medication. Participants in earlier trials found the therapy helpful and supportive. Overall, CTSP appears to be a safe option for those seeking to reduce suicidal thoughts.12345Why are researchers excited about this trial?
Researchers are excited about Cognitive Therapy for Suicide Prevention (CTSP) because it offers a tailored approach specifically designed to address suicidal thoughts and behaviors in homeless youth, a group with unique challenges. Unlike standard care options that might focus broadly on mental health through general counseling or medication, CTSP provides targeted therapy sessions aimed at understanding and altering the thoughts and behaviors that contribute to suicidal feelings. Additionally, the integration of booster sessions allows for ongoing support and reinforces the skills learned, potentially leading to more sustainable positive outcomes. This targeted and continuous approach could make a significant difference in preventing suicide in this vulnerable population.
What evidence suggests that Cognitive Therapy for Suicide Prevention might be an effective treatment for suicidal ideation in homeless youth?
Research has shown that Cognitive Therapy for Suicide Prevention (CTSP), which participants in this trial may receive, can greatly reduce suicidal thoughts in homeless youth. Studies have found that CTSP lowers both suicidal thoughts and feelings of hopelessness. Specifically, one study found that CTSP effectively reduced suicidal thoughts among homeless youth, who are often at high risk. The therapy includes structured sessions that aim to change negative thinking patterns and addresses related issues like substance use and depression. This makes CTSP a promising option for tackling the challenges faced by homeless youth.23467
Who Is on the Research Team?
Natasha Slesnick, Ph.D.
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for young people aged 15-24 who are experiencing homelessness, have a history of substance use, and show signs of suicidal behavior or have attempted suicide in the past year. They must be actively using alcohol or drugs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Therapy for Suicide Prevention (CTSP) + Services as Usual (SAU) or SAU alone over 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Therapy for Suicide Prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor